Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Biocon's profit in September quarter down y-o-y by 66%

15 Nov 2022 , 03:32 PM

Due to unusual charges relating to the introduction of a new tax regime of 25% and net tax of Rs14 crore toward the Viatris purchase, Biocon on Monday announced a 66% YoY decrease in net profit to Rs47 crore during Q2FY23.

On the strength of sales growth across its biosimilars, generics, and research services business segments, the profit before exceptional items reached Rs168 crore.

In the same quarter the year before, the pharmaceutical company reported a net profit of Rs188 crore. When compared to Q2FY22, total revenues increased 23% YoY to Rs2,384 crore from Rs1,945 crore.

In the second quarter of FY23, core profits before interest, taxes, depreciation, and amortization (EBITDA) increased 34% year over year to Rs816 crore, while core EBITDA margins increased 200 basis points to 35%.

In Q2FY23, Biocon Biologics, which accounts for 42% of sales, recorded a 34% YoY increase to Rs977 crore, while the generic business increased by 18% to Rs623 crore. To Rs768 crore, research services saw a 26% YoY increase.

R&D expenditures rose by 52% YoY this quarter to Rs252 crore as Biocon makes progress with the pipeline of biosimilar development.

Including up to $250 million through the sale of redeemable, non-convertible debentures and $275 million through the issue of commercial paper, Biocon's board has approved fundraising of $525 million on a private placement basis.

For feedback and suggestions, write to us at editorial@iifl.com

 

Related Tags

  • Biocon
  • Pharma
  • Q2 FY23
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.